Results 41 to 50 of about 2,546 (159)
Effects of curcumin and its derivatives on a glioma cell line
Glioblastomas are highly invasive brain tumors associated with oxidative stress (OS) and chronic inflammation. Curcumin (CUR), the principal bioactive compound of Curcuma longa, as well as its natural analogues demethoxycurcumin (DMC) and ...
Weronika Wiącek +2 more
doaj +1 more source
ABSTRACT This review examines recent advances in the use of natural deep eutectic solvents (NaDES) for natural product sample preparation, with emphasis on extraction, purification, analytical compatibility, and sustainability. NaDES emerge as versatile, tunable, and biocompatible media that enhance the recovery and stability of diverse phytochemicals ...
Valeria Cedeño‐Fierro +3 more
wiley +1 more source
ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin
We analyzed the role of ABCG2, a drug transporter, in determining the sensitivity of glioma stem cells (GSCs) to demethoxycurcumin (DMC). We first demonstrated that ABCG2 is more highly expressed in GSCs than primary astrocytes. Modulation of ABCG2 levels in GSCs by transfection of ABCG2 shRNA or a lentiviral vector encoding ABCG2 revealed an inverse ...
Chen, Long +3 more
openaire +3 more sources
Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells [PDF]
Demethoxycurcumin (DMC), a derivate of curcumin from natural plants, exerts antitumor effects on various human cancer cells in vitro and in vivo. Nevertheless, no reports have disclosed whether DMC can affect the growth of human cervical cancer cells in vivo.
Fu-Shin, Chueh +11 more
openaire +2 more sources
ABSTRACT Primary brain tumors are life‐threatening diseases. Glioblastoma is the most aggressive type with a poor prognosis. Medulloblastoma is the most common pediatric brain tumor. While surgical treatments often result in recurrences owing to the complex nature of the tumor microenvironment, conventional treatments lower the quality of life of ...
Ilkay Irem Ozbek +3 more
wiley +1 more source
This meta‐analysis of trials was conducted to assess the effect of nanocurcumin supplementation in type 2 diabetes mellitus. ABSTRACT Background Nanocurcumin has been developed to overcome the poor bioavailability of conventional curcumin and has been proposed as a potential adjunctive therapy for type 2 diabetes mellitus (T2DM).
Sahar Ghoflchi +5 more
wiley +1 more source
Demethoxycurcumin Preserves Renovascular Function by Downregulating COX‐2 Expression in Hypertension
Hypertension‐associated endothelial dysfunction is largely due to the exaggerated vasoconstrictor generation by cyclooxygenase‐2 (COX‐2). COX‐2 is induced under inflammatory condition. Demethoxycurcumin (DMC) is a major component of Curcuma longa L, which possesses anti‐inflammatory action.
Yingjuan Li +3 more
openaire +2 more sources
The biological activities of curcuminoids, the main polyphenol constituents of Curcuma longa (turmeric), have been the subject of many studies in recent years.
Andrea Mariela Araya-Sibaja +5 more
doaj +1 more source
Trong nghiên cứu này, phương pháp phân tích curcumin (1), demethoxycurcumin (2) và bisdemethoxycurcumin (3) đơn giản, dễ thực hiện với độ đặc hiệu, độ tin cậy cao bằng hệ thống sắc ký lỏng hiệu năng cao (HPLC) đã được xây dựng.
Nguyễn Phi Hùng +9 more
doaj
Curcumin Nanoformulations for Dermatological Applications: From Nutraceuticals to Nanocarriers
Nanotechnology‐based delivery platforms enhance the cutaneous administration of curcumin. Loading free curcumin into polymeric micelles, metal‐based nanoparticles, nanogels/hydrogels, liposomes, polymeric nanoparticles, or nanoemulsions/nanocrystals helps address its low solubility, poor stability and limited skin permeation. As a result, these systems
Stephany Celeste Gutiérrez‐Ruiz +13 more
wiley +1 more source

